- Home
- CBUS vs ALIS Comparison
CBUS vs ALIS Comparison
Compare CBUS & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBUS | ALIS |
|---|---|---|
| Founded | 2010 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.9M | 83.9M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CBUS | ALIS |
|---|---|---|
| Price | $1.57 | $10.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 299.6K | 33.2K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,794,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $109.96 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $9.85 |
| 52 Week High | $3.40 | $9.98 |
Technical Indicators
Market Signals| Indicator | CBUS | ALIS |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | N/A |
| Support Level | $1.46 | N/A |
| Resistance Level | $2.04 | N/A |
| Average True Range (ATR) | 0.25 | 0.00 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 9.82 | 0.00 |
Price Performance
Historical ComparisonAbout CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About ALIS Calisa Acquisition Corp Ordinary shares
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.